Responses
Abstracts accepted for publication
Rheumatoid arthritis - anti-TNF therapy
AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial
Compose a Response to This Article
Other responses
No responses have been published for this article.